[1] |
TIAN Lei, XIN Yu-qi, HUANG Meng-wei, WANG Xiao-hui.
Advances in the Treatment of Gynecological Malignancies during Pregnancy
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(6): 605-610.
|
[2] |
LOU Ning, NIU Yi-ru, MIAO Qin, XIE Li-mei, LIU Ya-min, FENG Rui-e.
Clinicopathologic Analysis and Literature Review of Ovarian Microcystic Stromal Tumor
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(5): 558-560.
|
[3] |
SUN Hao, WU Yu-xian, JIN Zhi-jun.
Research Progress of Exosomes as Diagnostic Biomarkers for Ovarian Cancer
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(5): 540-543.
|
[4] |
XIN Yu-qi, JU Yu-ye, WANG Xiao-hui.
Advances in Biomarkers and Early Diagnosis of Ovarian Cancer
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(5): 544-549.
|
[5] |
LI Yao-wei, LI Li.
The Value of Exosome Biomarkers in the Diagnosis and Prognostic Evaluation of Ovarian Cancer--Systematic Review
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(4): 462-468.
|
[6] |
JIANG Mei, YUE Wen-tao.
Research Progress of EZH2 in Ovarian Cancer
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(4): 425-428.
|
[7] |
WANG Xue, SHI Qiao-rui, WANG Xiao-hui.
Research Progress on Malignant Mechanism of Atypical Ovarian Endometriosis
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(4): 433-436.
|
[8] |
FENG Xue, WANG Li-qun, LU Mei-song.
Research Progress of Regulatory T Cells and Tumor Immunity of Ovarian Cancer
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(4): 429-432.
|
[9] |
WANG Ke-ruo, LI Hui-kai, QIN Yu.
Research Progress of DNA Damage Response Pathway Inhibitors in the Treatment of Ovarian Cancer
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(4): 437-442.
|
[10] |
DONG Qian, LONG Xiao-ran, DI Wen.
Long Non-Coding RNAs in Ovarian Cancer and Their Interaction with MicroRNAs
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(3): 327-331.
|
[11] |
ZHANG Kai, LIU Yu-lin, HU Jia-li, GUO Fei, XUE Feng-xia.
Expression and Prognostic of TOP2A in Ovarian Cancer: An Analysis Based on the Data-Mining of Oncomine and TCGA Databases
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(3): 345-349.
|
[12] |
XU Li-yuan, HOU Fan, WANG Liu-li, NIE Xia-zi, SHAO Rui-xue, WANG Hai-lin.
One Case of Primary Ovarian Squamous Cell Carcinoma and Literature Review
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(3): 358-360.
|
[13] |
ZHAO Shu-hui, YU Qing, WANG Min, ZHAO Zhe, WANG Yu-jia, YANG Shu-li.
Pregnancy with Ovarian Leiomyoma: A Case Report and Literature Review
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(3): 294-296.
|
[14] |
NIU Xing-yan, ZHANG Dong-ping, LI Fei-xia, PENG Yun-hua.
Advances in Chemotherapy for Ovarian Malignant Tumors
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(2): 125-128.
|
[15] |
ZHAO Qing,LIU Qian.
The Role of Long Non-Coding RNA in Chemotherapy Resistance of Ovarian Cancer
[J]. Journal of International Obstetrics and Gynecology, 2020, 47(2): 134-137.
|